Contract
Exhibit 10.47
May 16, 2005
Xxxxxxx X. Xxxxxx
Xxxxxx-Xxxx Pharmaceuticals, Inc.
0000 Xxxxxxxx Xxxx, Xxxxx 000
Xxx Xxxxx, XX 00000
Dear Xx. Xxxxxx:
The purpose of this letter agreement (Amendment 6) is to amend further the contract dated June 18, 2003. By signing below, the undersigned parties hereby agree to amend [ * ] of Exhibit B and replace them with [ * ] as reflected below:
[ * ]
Total | $ | 1,700,000 | |||
[ * ]
Page 1
[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. | ||||||||
By: |
/s/ X. Xxxxx |
/s/ X. Xxxxxxxx | ||||||
Xxxxxx X. Xxxxx, Ph.D. President and CEO |
Xxxxxxx X. Xxxxxxxx, III, M.D. Executive Vice President of Medical Affairs |
XXXXXX-XXXX PHARMACEUTICALS, INC. | ||||||||
By: |
/s/ Xxxxxxx X. Xxxxxx |
|||||||
Xxxxxxx X. Xxxxxx President |
Page 2